17
Participants
Start Date
November 30, 2003
Primary Completion Date
February 29, 2008
Study Completion Date
February 29, 2008
Rituxan, Cyclophosphamide, Vincristine, Prednisone
'Rituximab, Cyclophosphamide, Vincristine, Prednisone interventions are as follows: Rituximab will be administered as an IV infusion at the standard dose of 375 mg/m2 for 4 doses. However, the schedule of the infusions will be different than the usual one: Rather than administrating the 4 doses once weekly, the first infusion will be given 5 days (± 3 days) prior to the first infusions of C and V and oral P, and the following 3 rituximab infusions will be given on the same day as the 3 cycles of C, V, and P.
Higher Dose of Rituximab
rituximab 750mg/m2 (twice the standard dose of 375mg/m2) will be given weekly for 4 weeks. Premedication and infusion rate escalation will be exactly the same as for standard dose rituximab. The additional dose will thus run at 400ml/hr.
525 East 68th Street, New York
Collaborators (2)
Biogen
INDUSTRY
Genentech, Inc.
INDUSTRY
Weill Medical College of Cornell University
OTHER